PTP Accounts Production v24.2.0.383 02281302 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh022813022022-12-31022813022023-12-31022813022023-01-012023-12-31022813022021-12-31022813022022-01-012022-12-31022813022022-12-3102281302ns14:PoundSterling2023-01-012023-12-3102281302ns10:Director12023-01-012023-12-3102281302ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3102281302ns10:SmallEntities2023-01-012023-12-3102281302ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3102281302ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3102281302ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3102281302ns10:FullAccounts2023-01-012023-12-3102281302ns10:Director22023-01-012023-12-3102281302ns10:Director32023-01-012023-12-3102281302ns10:Director42023-01-012023-12-3102281302ns10:CompanySecretary12023-01-012023-12-3102281302ns10:RegisteredOffice2023-01-012023-12-3102281302ns5:CurrentFinancialInstruments2023-12-3102281302ns5:CurrentFinancialInstruments2022-12-3102281302ns5:ShareCapital2023-12-3102281302ns5:ShareCapital2022-12-3102281302ns5:RetainedEarningsAccumulatedLosses2023-12-3102281302ns5:RetainedEarningsAccumulatedLosses2022-12-3102281302ns5:PlantMachinery2023-01-012023-12-3102281302ns5:PlantMachinery2022-12-3102281302ns5:PlantMachinery2023-12-3102281302ns5:PlantMachinery2022-12-3102281302ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3102281302ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31022813021ns10:Director12022-12-31022813021ns10:Director12021-12-31022813021ns10:Director12023-01-012023-12-31022813021ns10:Director12022-01-012022-12-31022813021ns10:Director12023-12-31022813021ns10:Director12022-12-31
REGISTERED NUMBER: 02281302















Unaudited Financial Statements for the Year Ended 31 December 2023

for

BioBridge Limited

BioBridge Limited (Registered number: 02281302)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BioBridge Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: M Lloyd-Evans
C Lloyd-Evans
M Lloyd-Evans
R Lloyd-Evans





SECRETARY: C Lloyd-Evans





REGISTERED OFFICE: 3 St Peters Street
Duxford
Cambridge
CB22 4RP





REGISTERED NUMBER: 02281302





ACCOUNTANTS: Paul Glover Associates Limited
Progress House
Rowles Way
Swavesey
Cambridge
CB24 4UG

BioBridge Limited (Registered number: 02281302)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,648 710

CURRENT ASSETS
Debtors 5 5,223 52,611
Cash at bank 33,760 15,616
38,983 68,227
CREDITORS
Amounts falling due within one year 6 10,092 19,937
NET CURRENT ASSETS 28,891 48,290
TOTAL ASSETS LESS CURRENT
LIABILITIES

30,539

49,000

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 30,537 48,998
SHAREHOLDERS' FUNDS 30,539 49,000

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 September 2024 and were signed on its behalf by:





M Lloyd-Evans - Director


BioBridge Limited (Registered number: 02281302)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

BioBridge Limited is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 3 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023 13,296
Additions 1,486
At 31 December 2023 14,782
DEPRECIATION
At 1 January 2023 12,586
Charge for year 548
At 31 December 2023 13,134
NET BOOK VALUE
At 31 December 2023 1,648
At 31 December 2022 710

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 3,973 51,000
Other debtors 1,250 1,611
5,223 52,611

BioBridge Limited (Registered number: 02281302)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 843 169
Taxation and social security 5,039 10,840
Other creditors 4,210 8,928
10,092 19,937

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

31.12.23 31.12.22
£    £   
M Lloyd-Evans
Balance outstanding at start of year (1,278 ) (966 )
Amounts repaid (312 ) (312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,590 ) (1,278 )

The above advances and credits are repayable on demand and are interest free.